The development of human papillomavirus (HPV) vaccines and their potential for reducing cervical cancer incidence and mortality is generally considered an important step to improve population health worldwide. For countries without well performing cervical cancer screening programmes and lack of treatment options the current epidemiological and economic models seem applicable.

However, the assumptions underlying published …